Display Settings:

Format

Send to:

Choose Destination
Metabolism. 2013 Aug;62(8):1057-60. doi: 10.1016/j.metabol.2013.02.005. Epub 2013 Mar 15.

Independent association of the M2/ANXA5 haplotype with recurrent pregnancy loss (RPL) in PCOS patients.

Author information

  • 1Division of Gynecological Endocrinology and Reproductive Medicine, Department of Gynecology and Obstetrics, Klinikum der Ludwig-Maximilians-Universität, Munich, Campus Grosshadern, D-81377 Munich, Germany.

Abstract

OBJECTIVE:

The aim of this study was to analyze the contribution of the M2 haplotype of ANXA5 gene, previously identified as a risk factor for RPL and thrombophilia related pregnancy complications, to repeated miscarriage observed in PCOS patients.

PATIENTS/METHODS:

100 PCOS patients, 500 fertile women and 533 random population controls were genotyped for M2/ANXA5.

RESULTS:

M2 haplotype carriers faced a 3.4 fold elevated RPL risk (odds ratio 5.3, 95% confidence interval 3-9.2) compared to female fertile controls and 2.1 (odds ratio 2.6, 95% confidence interval 1.6-4.3) compared to population controls. The relative population risks in subgroups of PCOS patients with primary and secondary RPL were 2.3 (odds ratio 2.5, 95% confidence interval 1.2-5) and 3.3 (odds ratio 3.6, 95% confidence interval 1.5-8.4) respectively. As compared to the fertile women group, the relative risks equaled 4 (odds ratio 5, 95% confidence interval 2.3-10.8) and 6 (odds ratio 7.2, 95% confidence interval 3-17.7). Estimated relative risks for M2 carriers among PCOS RPL patients matched the values previously obtained for repeated miscarriage populations. The essential phenotypes, clinically defining PCOS, associated neither with RPL in their diagnostically relevant combinations, nor with M2 carriage as RPL risk factor in the PCOS RPL subgroups.

CONCLUSIONS:

M2/ANXA5 seems an independent RPL risk factor in PCOS patients that progressively correlates with the number of first trimester pregnancies. From our pilot study in PCOS women it appears relevant to offer M2/ANXA5 diagnostic analysis to such patients with RPL complications, to possibly guide proper therapeutic decisions.

Copyright © 2013 Elsevier Inc. All rights reserved.

KEYWORDS:

AF; ANXA5; Annexin A5; DNA; M2 haplotype of ANXA5; M2/ANXA5; PCOS; Polycystic ovarian syndrome; RPL; Recurrent miscarriage; Risk factor; allele frequency; annexin A5 gene or protein; deoxyribonucleic acid; polycystic ovarian syndrome; recurrent pregnancy loss

PMID:
23498654
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk